Campbell Murray is a experienced venture capital investor with a demonstrated history of working in the biopharma industry and life sciences. He is managing Director of Norvartis Venture Funds (NVF) in Cambridge, MA, USA. Prior to joining NVF, he worked at the Novartis Institutes for BioMedical Research as the Director of Special Projects. Campbell is originally from Auckland, New Zealand and a graduate of University of Auckland Medical School and previously worked at Auckland Hospital. He is a Kauffman Fellow and holds an MBA from Harvard Business School and an MPP (public policy) from the John F. Kennedy School of Government, where he was a Knox Fellow and Rotary Ambassadorial Scholar. Campbell serves as a director on the boards of Annexon, Expansion Therapeutics, Galera, and Lemonaid Health and is an observer on the board of Akouos.
This person is not in the org chart